By analyzing E. coli protein levels, scientists found a surplus of membrane shuttle proteins that may play a role in ...
Review of data from the trial found that the vaccine was not sufficiently effective at preventing invasive E coli disease ...
The FDA has approved Emblaveo with metronidazole for patients with complicated intra-abdominal infections and limited options.
AbbVie receives US FDA approval for Emblaveo to treat adults with complicated intra-abdominal infections with limited or no treatment options: North Chicago, Illinois Monday, Febr ...
A Cornell University-led collaboration has uncovered the equipment that enables bacteria to survive exposure to antibiotics: ...
Ten months after Pfizer scored approval in Europe for Emblaveo (aztreonam and avibactam) to treat complicated intra-abdominal infections (cIAIs), AbbVie has done the same in the U.S., ...
Hosted on MSN4d
The Antibiotic Arms Race: Can Science Stay Ahead of Rapidly Evolving Antibiotic-Resistant Bacteria?A study reveals alarming rates of antibiotic resistance in Gram-negative bacteria, highlighting the urgent need for ...
GlobalData on MSN4d
FDA approves AbbVie’s Emblaveo for intra-abdominal infectionsAbbVie has received US Food and Drug Administration (FDA) approval for Emblaveo (aztreonam and avibactam) to be used in ...
The intravenous antibiotic Emblaveo, a combination of aztreonam and avibactam approved in Europe last year, was developed in ...
CAMBRIDGE, MA AND PITTSBURGH, PA / ACCESS Newswire / February 10, 2025 / Next Gen Diagnostics (NGD), a pioneer in the development of machine learning models for whole genome sequence- (WGS-) based det ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback